Clinical Trial Update: Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on ORL-1G (D-galactose) for glycogen storage disease type 14, currently in Phase 1/2 with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type 14

Drugs mentioned

• ORL-1G (D-galactose)

Snippet

Sponsor: Orpha Labs | Conditions: Glycogen Storage Disease, Type 14 | Phase 1, Phase 2 | Status: UNKNOWN